Synthetic antigen medicine: Usage and care is completely decomposition. Understanding their use and attention is essential for the rehabilitation and safety of patients.
1. Fluconium: In the case of pyromococcal disease, it is common to have dysentery infection at 200 mg for the first dose, 100 mg per day thereafter, for at least 2 weeks. Esophthalmosis, first dose, 200 mg, then 100 – 200 mg per day, for at least three weeks or more. For hidden fungus meningitis, the usual dose is 400 mg on the first day and 200-400 mg per day thereafter, with specific treatments to be determined by a doctor depending on the condition and generally longer. 2. Ictarconium: The treatment of skin fungi diseases, such as gills, gills, etc., is typically 100 mg – 200 mg/day, and the treatment ranges from 1-2 weeks depending on the condition. In the case of alpha fungi, shock therapy is 200 mg per day, two times per day, one week in a row, three weeks off drugs, one shock treatment, and finger fungi generally requires 2 – 3 shock treatments, and toe toe fungi may require 3 – 4 shock treatments. (ii) E.V.D. 1. V.C.: In the treatment of serious fungi infections such as invasive entropy, first a load dose of 6 mg/kg for weight 40kg, 6 mg/kg for weight < 40kg for weight, 4 mg/kg for weight < 40kg for weight 12 hours, 4 mg/kg for weight 40kg for weight maintenance, and 4 mg/kg for weight 40kg for weight < 40kg for weight, 3 mg/kg for weight 12 hours. Drills should not be too fast and are generally contained within 3 mg/kg per hour to avoid adverse reactions. 2. Carpofon Net: For pyrophyllosis and other pyromoccus infections, a single dose of 70 mg was given on the first day, followed by a maintenance dose of 50 mg per day. In the case of invasive aroma, a 70 mg load dose was given on the first day, followed by 50 mg per day, with an intravenous drip of more than one hour.
1. Gastrointestinal response: Many synthetic antigens can cause gastrointestinal discomfort, vomiting, diarrhoea and abdominal pain. During the use of the drug, the patient must be aware that the diet is low and, if the symptoms seriously affect the food intake and quality of life, the doctor should be informed in a timely manner that the programme may need to be adjusted or treated. 2. Hepatic toxicity: This is one of the more prominent adverse effects of synthetic antigens. For example, fluorine, Ethraconium, etc. can cause hepatic abnormalities during long-term or large-dose use. In the course of the drug use, hepatic function is regularly examined, and hepatic impairments such as inactivity, abated appetite and yellow salivation are immediately discontinued and treated accordingly. 1. Effects of metabolism with other drugs: Synthetic antigens may affect metabolism with other drugs. For example, fluorine inhibits cytochrome P450 enzymes, increases blood concentration and increases the risk of haemorrhage or drug poisoning for certain drugs (e.g. Wafalin, benzo-Pentol, etc.). Thus, in the use of synthetic anti-fouling drugs, the patient informs the doctor about other drugs that are being used and the doctor needs to assess the possibilities of the interaction of drugs in a comprehensive manner. 2. Interaction with food: The absorption of part of the antigen medicine is influenced by food. For example, the Ectarconium needs to be taken immediately after the meal in order to promote the absorption of drugs and to increase bioavailability, while the absorption of the oral formulations of fluoride is not influenced by food. 1. Pregnant and lactating women: The use of most synthetic antigens in pregnant and lactating women requires caution. For example, fluorine is a potential risk to the foetus when pregnant women use it, especially at high doses or long-term use. Breast-feeding women may use a small amount of drugs that are distributed through milk, which affects infants and are generally not recommended for use, and if needed, it should be decided by a doctor after a trade-off. 2. Older persons and children: the liver and kidney function of older persons may be reduced, drug metabolism and excretion may be reduced, and the dose may need to be adjusted when used. The doses used by children using synthetic antigen drugs usually need to be calculated on the basis of body weight or surface area and the adverse effects are closely observed.
In short, synthetic antifabric drugs play an irreplaceable role in the treatment of fungal infections, but the right amount of use and the importance of attention are key to ensuring treatment effectiveness and patient safety. Patients are strictly required to follow medical instructions during their use, and in case of unusual and timely medical treatment.
